Singapore markets closed

Regeneron Pharmaceuticals, Inc. (REGN)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
894.38+0.39 (+0.04%)
As of 01:00PM EDT. Market open.
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Assets
Current assets
Cash
Cash and cash equivalents
2,730,000
3,105,900
2,885,600
2,193,700
Other short-term investments
8,114,800
4,636,400
2,809,100
1,393,300
Total cash
10,844,800
7,742,300
5,694,700
3,587,000
Net receivables
5,667,300
5,328,700
6,036,500
4,114,700
Inventory
2,580,500
2,401,900
1,951,300
1,916,600
Other current assets
386,600
411,200
332,400
160,800
Total current assets
19,479,200
15,884,100
14,014,900
9,779,100
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
6,125,200
5,432,200
4,880,300
4,352,700
Accumulated depreciation
-1,978,800
-1,669,200
-1,398,100
-1,131,100
Net property, plant and equipment
4,146,400
3,763,000
3,482,200
3,221,600
Equity and other investments
5,396,500
6,591,800
6,838,000
3,135,600
Intangible assets
1,038,600
915,500
-
-
Other long-term assets
444,100
336,400
216,100
168,100
Total non-current assets
13,601,000
13,330,400
11,419,900
7,384,200
Total assets
33,080,200
29,214,500
25,434,800
17,163,300
Liabilities and stockholders' equity
Liabilities
Current liabilities
Accounts payable
606,600
589,200
564,000
475,500
Taxes payable
-
300
326,300
19,500
Accrued liabilities
2,357,900
2,074,200
1,593,100
1,608,600
Deferred revenues
458,900
477,900
442,000
577,700
Other current liabilities
-
-
-
122,400
Total current liabilities
3,423,400
3,141,300
3,932,500
2,697,400
Non-current liabilities
Long-term debt
1,982,900
1,981,400
1,980,000
1,978,500
Deferred revenues
126,700
69,800
73,300
57,800
Other long-term liabilities
854,100
638,000
680,200
687,100
Total non-current liabilities
3,683,700
3,409,200
2,733,500
3,440,600
Total liabilities
7,107,100
6,550,500
6,666,000
6,138,000
Stockholders' equity
Common stock
100
100
100
100
Retained earnings
27,260,300
23,306,700
18,968,300
10,893,000
Accumulated other comprehensive income
-80,900
-238,800
-26,200
29,300
Total stockholders' equity
25,973,100
22,664,000
18,768,800
11,025,300
Total liabilities and stockholders' equity
33,080,200
29,214,500
25,434,800
17,163,300